<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-U4GB8PEV</identifier><date>2010</date><creator>Godić, Aleksandar</creator><relation>documents/doc/U/URN_NBN_SI_doc-U4GB8PEV_001.pdf</relation><relation>documents/doc/U/URN_NBN_SI_doc-U4GB8PEV_001.txt</relation><format format_type="issue">1</format><format format_type="volume">14</format><format format_type="type">article</format><format format_type="extent">str. 19</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">259808000</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-U4GB8PEV</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">dermatologija</subject><subject language_type_id="slv">limfom</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">retinoidi</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Uporaba retinoidov pri zdravljenju T-celičnih limfomov</title></Record>